GIP
TXG icon

Granite Investment Partners’s 10x Genomics TXG Stock Holding History

Granite Investment Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-409,786
Closed -$9.25M – 274
2024
Q3 		$9.25M Sell
409,786
-51,227
-11% -$1.06M 0.4% 89
2024
Q2 		$8.97M Sell
461,013
-48,020
-9% -$1.26M 0.37% 89
2024
Q1 		$19.1M Buy
+509,033
New +$22.4M 0.73% 50

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Granite Investment Partners's TXG Position: Q4 2024 in Review

Granite Investment Partners sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 409,786 shares — an estimated $9.25M sold.

Granite Investment Partners first reported a position in TXG in Q1 2024 and held it in 3 quarters. The position peaked at $19.1M in Q1 2024. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • Granite Investment Partners reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • Granite Investment Partners sold 409,786 10x Genomics shares in Q4 2024, an estimated $9.25M.
  • Granite Investment Partners first reported a position in 10x Genomics in Q1 2024 and held it in 3 quarters.
  • Granite Investment Partners's 10x Genomics position peaked at $19.1M in Q1 2024.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on Granite Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.